학술논문
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia
Document Type
Article
Author
Source
In Blood Advances 11 May 2021 5(9):2438-2446
Subject
Language
ISSN
2473-9529